Connected Drug Delivery Devices Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the connected drug delivery devices market grown in recent years?
The market size of connected drug delivery devices has seen an exponential increase in the recent past. The market growth is projected to rise from $7.48 billion in 2024 to $9.29 billion in 2025, with a compound annual growth rate (CAGR) of 24.2%. The growth during the historical period is credited to heightened awareness of connected devices, growing significance of remote monitoring for medication compliance, increased patient involvement, extensive consumer adoption, and the sharply rising cost of medical management.
How is the connected drug delivery devices market size expected to evolve during the forecast period?
We anticipate the market for connected drug delivery devices to experience significant growth in upcoming years. This market is predicted to expand to $21.92 billion by 2029, reflecting a compound annual growth rate (CAGR) of 23.9%. The forecasted growth could be influenced by factors such as higher prevalence of chronic diseases, greater patient awareness and adherence to recommended treatments, rapid advancements in healthcare technology infrastructure, an increased focus on preventive care, as well as the widespread utilization of connected devices for managing electronic health records (EHR) in laboratories and hospitals. Future trends anticipated within this period involve accelerated R&D activities, a boost in technological innovation and enhanced device connectivity, increased application of machine learning and AI, growing incorporation of telehealth platforms with AR/VR technologies, and a rise in the usage of electronic technology within healthcare devices.
Get your connected drug delivery devices market report here!
Which key drivers are propelling the connected drug delivery devices market’s growth?
The anticipated expansion of the connected drug delivery device market is linked to the rising significance of remote patient monitoring. This method of healthcare delivery, which employs technology to monitor patients’ health and medical data remotely, is complemented by connected drug delivery devices. Through these devices, it’s possible to accurately monitor how patients adhere to their medication schedule, as well as trigger crucial interventions when required, and offer tailored care management. A US-based digital health solutions company, Vivalink Inc., conducted a survey in August 2023, which found a 305% surge in clinicians utilizing remote patient monitoring, rising from 20% in 2021 to 81% presently. Furthermore, a vast majority, 84%, of these users intend to broaden their use of RPM in 2024. Thus, the enhanced focus on remote patient monitoring is contributing to the advancement of the connected drug delivery device market.
What are the market segments in the connected drug delivery devices industry?
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software
2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp
Which leading companies are shaping the growth of the connected drug delivery devices market?
Major players in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Bayer AG, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Medtronic PLC, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck Group, Becton Dickinson and Company, GlaxoSmithKline PLC, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, OPKO Health Inc., Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, and Findair Sp. z.o.o.
What key trends are currently impacting the connected drug delivery devices market’s development?
Leading businesses in the connected drug delivery devices market are concentrating on the creation of innovative technologies, like digital respiratory health solutions, to boost their market profitability. A digital respiratory health solution in the context of connected drug delivery devices refers to a tech-savvy device that delivers medication to the respiratory system, monitors usage, and collects health data to improve patient results. For example, in February 2022, AptarGroup Inc., an American firm specializing in dispensing packaging and drug delivery devices, launched HeroTracker Sense. This groundbreaking digital tool converts traditional metered-dose inhalers into intelligent, connected devices to improve medication compliance and management for people suffering from chronic respiratory diseases such as asthma and COPD among others. It provides sensors for enhanced analytics and insights, and supports patient adherence tracking through the BreatheSmart app, contributing to the efficient treatment of respiratory diseases.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13962
Which geographic areas are influencing the growth of the connected drug delivery devices market?
North America was the largest region in the connected drug delivery market in 2024. The regions covered in the connected drug delivery device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Oncology Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report
Lancing Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/lancing-devices-and-equipment-global-market-report
Neurostimulation Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
